Exploring and sharing new medicines for your patients
The bioSimilia initiative brings the benefits of ultra-minute nano-pharmacological substances to alleviate many disease conditions. Eminent physician cum researcher Dr Rajesh Shah, MD, has been currently working on researching COVID-19 Nosode. BiosimCovex is a COVID-19 Nosode. We scientifically prepared three variants of COVID-19 Nosode at Mumbai’s Haffkine Institute and Gujarat University. They have undergone pre-clinical and clinical evaluation. Scientific information and research findings of the COVID-19 Nosode are shared on this website.
Phase 1, Phase 2, and Phase 3 studies with BiosimCovex have shown encouraging results. We have submitted our proposal for Emergency Approval to the Government of India, Ministry of Health and Family Welfare. BiosimCovex is currently undergoing a review process by various regulatory agencies.